Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer

M Mimeault ¹, S K Batra

⁰Department of Biochemistry and Molecular Biology, Eppley Institute for Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA. mmimeault@unmc.edu

Gut +

|

September 16, 2008

View abstract on PubMed

Summary

Adult pancreatic stem cells offer potential for diabetes therapy. However, alterations can lead to pancreatic cancer stem cells, requiring targeted therapies for advanced disease.

Area Of Science

Cell Biology
Regenerative Medicine
Oncology

Background

Adult pancreatic stem/progenitor cells and beta cell precursors may persist in the adult pancreas.
These cells offer potential for in vivo expansion and differentiation for diabetes treatment.
Stem/progenitor cells from various sources can be used for beta cell replacement therapies.

Purpose Of The Study

To explore the therapeutic potential of adult pancreatic stem/progenitor cells for diabetes.
To investigate the role of genetic/epigenetic alterations in pancreatic stem/progenitor cell dysfunction and cancer.
To identify signaling pathways involved in pancreatic cancer stem/progenitor cell growth and resistance.

Main Methods

Review of recent advancements in pancreatic stem/progenitor cell research.
Analysis of signaling cascades implicated in pancreatic cancer stem/progenitor cell development.
Exploration of targeted therapeutic strategies for pancreatic cancer.

Main Results

Adult pancreatic stem/progenitor cells hold promise for treating diabetes mellitus.
Dysfunctional pancreatic stem/progenitor cells can transform into pancreatic cancer stem/progenitor cells.
Signaling pathways like hedgehog, EGF-EGFR, Wnt/beta-catenin, and SDF-1/CXCR4 are crucial for pancreatic cancer stem/progenitor cell survival and resistance.

Conclusions

Targeted therapies combining drug regimens against oncogenic elements and conventional chemotherapy offer promising strategies for pancreatic cancer.
These novel approaches could lead to more effective treatments for locally advanced and metastatic pancreatic cancers.
Further research into pancreatic stem/progenitor cell biology is crucial for advancing diabetes and cancer therapies.

Related Concept Videos